This summer Titania cybersecurity expert, Gregory Carpenter, has been presenting his research paper entitled, Cyber Medical Terrorism: Hacking DNA for a Brave New World at numerous venues which include the 5th Annual Cyber Security Training & Technology Forum (CSTTF) in Colorado Springs, NOLACon in the “Big Easy”, as well as Hacker Halted in Atlanta and various TakedownCon security conferences. In October, he will present at BesidesCon in Ottawa, Ontario which will include both his presentation and a panel appearance on the ethical use of biomedical technology.
Greg joined Titania in 2013, following his honorable service of more than 27 years in the U.S. Army. Today, he supports numerous Titania customers and their critical missions. A service-disabled veteran, Greg’s military service included combat tours, Medical Service, Intelligence, and Information Operations assignments, among others. Following his military career, he served as a defense department civilian running the Division Operations office in NYC during recovery operations on and after 9-11. Additionally, he managed the Counterintelligence office at the Army Research Labs and worked in ARCYBER. He is highly sought after to speak, train, and educate people, agencies, and organizations on cybersecurity-related matters and is focused on integrating his cybersecurity background with his extensive medical experience by targeting his research efforts towards improving medical device security through anti-hacking nanotechnology.
Greg is pursuing his doctorate in public health (Dr. PH) and focusing his studies on bionanotechnology; specifically the implications of marginal security embedded in nanorobotics. In past speaking engagements, Greg spoke at The International Fellow’s Program at NIU as a panelist to discuss Advanced Persistent Threats (APTs). This is the main subject of Reverse Deception: Organized Cyber Threat Counter-Exploitation, a book Greg co-authored that is being added to the NIU curriculum and details best business practices to defend against APT’s.